Immunovia AB (IMMVF)
OTHER OTC:IMMVF
Holding IMMVF?
Track your performance easily

Immunovia AB (IMMVF) Financial Statements

4 Followers

Immunovia AB Financial Overview

Immunovia AB's market cap is currently ―. The company's EPS TTM is $-0.571; its P/E ratio is -0.26; Immunovia AB is scheduled to report earnings on August 5, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenuekr 358.00Kkr 103.00Kkr 182.00Kkr 305.00Kkr 377.00K
Gross Profitkr -1.10Mkr -476.00Kkr -1.07Mkr -554.00Kkr -2.30M
EBITkr -22.54Mkr -33.31Mkr -43.70Mkr -49.15Mkr -35.78M
EBITDAkr -16.41Mkr -26.98Mkr -37.49Mkr -42.95Mkr -29.57M
Net Income Common Stockholderskr -22.93Mkr -33.73Mkr -44.11Mkr -47.13Mkr -36.13M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investmentskr 158.84Mkr 197.45Mkr 239.80Mkr 287.41Mkr 339.17M
Total Assetskr 360.80Mkr 403.89Mkr 449.55Mkr 493.81Mkr 551.80M
Total Debtkr 39.87Mkr 40.39Mkr 40.75Mkr 33.26Mkr 34.53M
Net Debtkr -118.97Mkr -157.06Mkr -199.05Mkr -254.14Mkr -304.63M
Total Liabilitieskr 64.54Mkr 64.90Mkr 62.49Mkr 59.91Mkr 67.39M
Stockholders Equitykr 296.25Mkr 338.99Mkr 387.06Mkr 433.90Mkr 484.41M
Cash Flow-
Free Cash Flowkr -37.48Mkr -41.81Mkr -46.64Mkr -50.82Mkr -41.12M
Operating Cash Flowkr -37.41Mkr -40.89Mkr -46.08Mkr -50.11Mkr -38.29M
Investing Cash Flowkr -63.00Kkr -923.00Kkr -561.00Kkr -539.00Kkr -2.83M
Financing Cash Flowkr -1.47Mkr -1.06Mkr -1.34Mkr -1.44Mkr -1.43M
Currency in SEK

Immunovia AB Earnings and Revenue History

Immunovia AB Debt to Assets

Immunovia AB Cash Flow

Immunovia AB Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis